Molnupiravir has major safety concerns, hence not part of National Protocol: ICMR chief Balram Bhargava Medical Dialogues Bureau6 Jan 2022 6:14 AM GMTNew Delhi: Pointing out to some major saftey concerns including teratogenicity, mutagenicity and also potential to cause cartilage damage and muscle...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 10:23 AM GMT'Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high ...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 2:06 PM GMTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Mankind Pharma unveils anti COVID 19 pill Molulife Roshni Dhar1 Jan 2022 5:15 AM GMTTaking a significant step towards countering COVID-19 in India, drug major Mankind Pharma has announced the launch of the oral anti- COVID pill...
Health Bulletin 31/December/2021 Roshni Dhar31 Dec 2021 11:30 AM GMTHere are Top Health stories of the dayFMGE December Result 2021 (OUT): NBE announces Foreign Medical Graduate Examination for December SessionThe...
Mankind Pharma Launches Anti-COVID-19 pill Molulife- Molnupiravir 200mg Ruchika Sharma30 Dec 2021 7:33 AM GMTTaking a significant step towards countering COVID-19 in India, drug major Mankind Pharma has announced the launch of the oral anti- COVID...
